No Data
No Data
ASX Midday Sector Update: Materials Sector Soars, Healthcare Struggles
Why Clinuvel, Orthocell, Vulcan, and Wildcat Shares Are Storming Higher
Clinuvel Stroke Drug Shows 'Positive' Results – but Some Adverse Effects Left Unclear
Clinuvel Pharmaceuticals Reports Positive Study Results for Arterial Ischaemic Stroke Drug Candidate
Imugene Appoints CFO; Shares Fall 3%
Clinuvel Pharmaceuticals Price Target Cut 2.2% to A$21.75/Share by Bell Potter